{{noteTA|G1=LS}}
'''神经氨酸酶抑制剂'''（neuraminidase inhibitors，NAIs）是一类抑制[[神经氨酸酶|神经氨酸酶]]活性的[[抗病毒药物|抗病毒药物]]。其-{zh-cn:通过;zh-tw:透過}-阻断流感病毒的神经氨酸酶，从而阻止病毒[[出芽生殖|出芽]]，进而抑制病毒繁殖。神经氨酸酶抑制剂包括[[奥司他韦|奥司他韦]]（达菲）（一种[[前体药物|前药]]）、扎那米韦（乐感清）、拉尼米韦（Inavir）、帕拉米韦及一系列正在研发中的新药。与仅对甲型流感起作用的M2离子通道蛋白抑制剂不同，神经氨酸酶抑制剂对[[甲型流感病毒|甲型]][[乙型流感病毒|流感]]和[[乙型流感病毒|乙型流感]]均有效 <ref>{{Cite journal|title=Structural Studies of the Resistance of Influenza Virus Neuramindase to Inhibitors|last=Smith|first=B. J.|last2=McKimm-Breshkin|first2=J. L.|journal=Journal of Medicinal Chemistry|issue=11|doi=10.1021/jm010528u|year=2002|volume=45|pages=2207–12|pmid=12014958|last3=McDonald|first3=M.|last4=Fernley|first4=R. T.|last5=Varghese|first5=J. N.|last6=Colman|first6=P. M.|authorlink6=Peter Colman}}</ref> <ref>{{Cite journal|title=Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors|url=https://www.researchgate.net/publication/8541991|last=Gubareva|first=Larisa V|journal=Virus Research|issue=1–2|doi=10.1016/j.virusres.2004.02.034|year=2004|volume=103|pages=199–203|pmid=15163510}}</ref> <ref>[http://www.pharmasquare.org/flash/Tamiflu.html This flash animation shows the mode of action of oseltamivir (Tamiflu)] {{Webarchive|url=https://web.archive.org/web/20051023004002/http://www.pharmasquare.org/flash/Tamiflu.html|date=2005-10-23}}. pharmasquare.org</ref><ref>[http://www.portfolio.mvm.ed.ac.uk/studentwebs/session2/group21/replicat.htm Replication of influenza virus] {{Wayback|url=http://www.portfolio.mvm.ed.ac.uk/studentwebs/session2/group21/replicat.htm |date=20210128145347 }}. mvm.ed.ac.uk</ref>。

神经氨酸酶抑制剂[[奥司他韦|奥司他韦]]和扎那米韦在美国和欧洲被批准用于治疗和预防流感。帕拉米韦-{zh-cn:通过;zh-tw:透過}-结合并抑制流感病毒的神经氨酸酶活化而产生药理活性，其作用时间比[[奥司他韦|奥司他韦]]和扎那米韦都要长。 <ref>{{Cite journal|title=Anti-influenza virus activity of peramivir in mice with single intramuscular injection|last=Bantia|first=Shanta|last2=Arnold|first2=C. Shane|date=1 January 2006|journal=Antiviral Research|issue=1|doi=10.1016/j.antiviral.2005.10.002|volume=69|pages=39–45|issn=0166-3542|pmid=16325932|last3=Parker|first3=Cynthia D.|last4=Upshaw|first4=Ramanda|last5=Chand|first5=Pooran}}</ref>拉尼米韦从细胞中缓慢释放进入呼吸道，其抗流感病毒作用同样持久，但其维持持久作用的机理不同于帕拉米韦<ref>{{Cite journal|title=Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers|url=https://archive.org/details/sim_journal-of-clinical-pharmacology_2010-11_50_11/page/1319|last=Ishizuka|first=Hitoshi|last2=Yoshiba|first2=Satoshi|date=1 November 2010|journal=Journal of Clinical Pharmacology|issue=11|doi=10.1177/0091270009356297|volume=50|pages=1319–1329|issn=1552-4604|pmid=20145259|last3=Okabe|first3=Hiromi|last4=Yoshihara|first4=Kazutaka}}</ref>。

近年来，神经氨酸酶抑制剂的疗效备受争议<ref>{{cite journal|last1=Jefferson|first1=Tom|last2=Jones|first2=Mark|last3=Doshi|first3=Peter|last4=Spencer|first4=Elizabeth A.|last5=Onakpoya|first5=Igho|last6=Heneghan|first6=Carl J.|title=Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments|journal=BMJ|date=9 April 2014|volume=348|pages=g2545|doi=10.1136/bmj.g2545|url=http://www.bmj.com/content/348/bmj.g2545|issn=1756-1833|pmid=24811411|pmc=3981975|access-date=2021-01-15|archive-date=2019-10-31|archive-url=https://web.archive.org/web/20191031002131/https://www.bmj.com/content/348/bmj.g2545|dead-url=no}}</ref><ref>{{cite journal|last1=Hsu|first1=Jonathan|last2=Santesso|first2=Nancy|last3=Mustafa|first3=Reem|last4=Brozek|first4=Jan|last5=Chen|first5=Yao Long|last6=Hopkins|first6=Jessica P.|last7=Cheung|first7=Adrienne|last8=Hovhannisyan|first8=Gayane|last9=Ivanova|first9=Liudmila|last10=Flottorp|first10=Signe A.|last11=Saeterdal|first11=Ingvil|last12=Wong|first12=Arthur D.|last13=Tian|first13=Jinhui|last14=Uyeki|first14=Timothy M.|last15=Akl|first15=Elie A.|last16=Alonso-Coello|first16=Pablo|last17=Smaill|first17=Fiona|last18=Schünemann|first18=Holger J.|title=Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies|journal=Annals of Internal Medicine|date=3 April 2012|volume=156|issue=7|pages=512–524|doi=10.7326/0003-4819-156-7-201204030-00411|issn=1539-3704|pmid=22371849|pmc=6679687}}</ref><ref>{{cite journal|last1=Heneghan|first1=Carl J.|last2=Onakpoya|first2=Igho|last3=Thompson|first3=Matthew|last4=Spencer|first4=Elizabeth A.|last5=Jones|first5=Mark|last6=Jefferson|first6=Tom|title=Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments|journal=BMJ|date=9 April 2014|volume=348|pages=g2547|doi=10.1136/bmj.g2547|url=http://www.bmj.com/content/348/bmj.g2547|issn=1756-1833|pmid=24811412|pmc=3981976|access-date=2021-01-15|archive-date=2021-03-23|archive-url=https://web.archive.org/web/20210323001946/https://www.bmj.com/content/348/bmj.g2547|dead-url=no}}</ref>。然而，在[[2009年H1N1流感大流行|2009年H1N1流感大流行]]之后，许多国家和地区都宣称流感早期使用神经氨酸酶抑制剂治疗可有效减少严重病例和死亡率<ref>{{cite journal|last1=Louie|first1=Janice K.|last2=Acosta|first2=Meileen|last3=Jamieson|first3=Denise J.|last4=Honein|first4=Margaret A.|title=Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California|journal=New England Journal of Medicine|volume=362|issue=1|pages=27–35|doi=10.1056/nejmoa0910444|pmid=20032319|year=2010}}</ref><ref>{{cite journal|last1=Jain|first1=Seema|last2=Kamimoto|first2=Laurie|last3=Bramley|first3=Anna M.|last4=Schmitz|first4=Ann M.|last5=Benoit|first5=Stephen R.|last6=Louie|first6=Janice|last7=Sugerman|first7=David E.|last8=Druckenmiller|first8=Jean K.|last9=Ritger|first9=Kathleen A.|last10=Chugh|first10=Rashmi|last11=Jasuja|first11=Supriya|last12=Deutscher|first12=Meredith|last13=Chen|first13=Sanny|last14=Walker|first14=John D.|last15=Duchin|first15=Jeffrey S.|last16=Lett|first16=Susan|last17=Soliva|first17=Susan|last18=Wells|first18=Eden V.|last19=Swerdlow|first19=David|last20=Uyeki|first20=Timothy M.|last21=Fiore|first21=Anthony E.|last22=Olsen|first22=Sonja J.|last23=Fry|first23=Alicia M.|last24=Bridges|first24=Carolyn B.|last25=Finelli|first25=Lyn|title=Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009|journal=New England Journal of Medicine|date=12 November 2009|volume=361|issue=20|pages=1935–1944|doi=10.1056/NEJMoa0906695|issn=0028-4793|pmid=19815859|citeseerx=10.1.1.183.7888}}</ref><ref>{{cite journal|last1=Domínguez-Cherit|first1=Guillermo|last2=Lapinsky|first2=Stephen E.|last3=Macias|first3=Alejandro E.|last4=Pinto|first4=Ruxandra|last5=Espinosa-Perez|first5=Lourdes|last6=de la Torre|first6=Alethse|last7=Poblano-Morales|first7=Manuel|last8=Baltazar-Torres|first8=Jose A.|last9=Bautista|first9=Edgar|last10=Martinez|first10=Abril|last11=Martinez|first11=Marco A.|last12=Rivero|first12=Eduardo|last13=Valdez|first13=Rafael|last14=Ruiz-Palacios|first14=Guillermo|last15=Hernández|first15=Martín|last16=Stewart|first16=Thomas E.|last17=Fowler|first17=Robert A.|title=Critically Ill patients with 2009 influenza A(H1N1) in Mexico|url=https://archive.org/details/sim_jama_2009-11-04_302_17/page/1880|journal=JAMA|date=4 November 2009|volume=302|issue=17|pages=1880–1887|doi=10.1001/jama.2009.1536|issn=1538-3598|pmid=19822626|doi-access=free}}</ref><ref name="ZarychanskiStuart2010">{{cite journal|last1=Zarychanski|first1=R.|last2=Stuart|first2=T. L.|last3=Kumar|first3=A.|last4=Doucette|first4=S.|last5=Elliott|first5=L.|last6=Kettner|first6=J.|last7=Plummer|first7=F.|title=Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection|journal=Canadian Medical Association Journal|volume=182|issue=3|year=2010|pages=257–264|issn=0820-3946|doi=10.1503/cmaj.091884|pmid=20093297|pmc=2826467}}</ref>。

统计报告显示，全国/地区范围内使用神经氨酸酶抑制剂治疗流感样疾病的国家和地区中，有症状感染者的死亡率很低，这是因为这些国家普遍在流感患者感染早期便使用神经氨酸酶抑制剂<ref name="ncbi.nlm.nih.gov">{{cite journal|last1=Sugaya|first1=Norio|title=Widespread use of neuraminidase inhibitors in Japan|journal=Journal of Infection and Chemotherapy|date=1 October 2011|volume=17|issue=5|pages=595–601|doi=10.1007/s10156-011-0288-0|issn=1437-7780|pmid=21850418}}</ref>。尽管这些国家和地区广泛使用奥司他韦，但尚未出现对奥司他韦具有耐药性的流感病毒引起的[[疾病爆发|爆发]]，也没有出现对奥司他韦具有耐药性的流感病毒引起的严重疾病的报道<ref name="ncbi.nlm.nih.gov"/>。[[美国疾病控制与预防中心|美国疾病控制中心]]仍然建议并发症相关高危人群，老年人以及首次出现流感相关症状后48小时内的低危人群使用奥司他韦治疗流感<ref name="autogenerated1">{{cite web |url=https://www.cdc.gov/media/haveyouheard/stories/Influenza_antiviral2.html |title=CDC Online Newsroom - "Have You Heard?" Archive: 2014 - Influenza A Variant Virus |work=cdc.gov |access-date=2021-01-15 |archive-date=2017-01-18 |archive-url=https://web.archive.org/web/20170118062432/https://www.cdc.gov/media/haveyouheard/stories/Influenza_antiviral2.html |dead-url=no }}</ref>。

神经氨酸酶抑制剂常见的副作用为恶心和呕吐。已有报道称儿童服用奥司他韦后可出现行为异常，如[[譫妄|谵妄]]和[[幻觉|幻觉]]，这可能是流感相关症状的延伸<ref name="ncbi.nlm.nih.gov"/>。这些副作用一般发生于流感早期，即流感病发后48小时内。因此，专家建议，无论患儿是否接受神经氨酸酶抑制剂治疗，父母都应密切监视流感病发后48小时内的患儿体征<ref name="ncbi.nlm.nih.gov"/>。

==常见神经氨酸酶抑制剂==
*[[奥司他韦|奥司他韦]] (达菲)
*[[帕拉米韦|帕拉米韦]] (Rapivab)
*[[扎那米韦|扎那米韦]] (乐感清)
*[[拉尼米韦|拉尼米韦]]

===临床使用的神经氨酸酶抑制剂结构===
{| class="wikitable" style="margin: 1em auto 1em auto;"
|+ Viral neuraminidase inhibitors in use
|-
| [[File:Zanamivir_structure.svg|200x200px]]
| [[File:Oseltamivir.svg|220x250px]]
| [[File:Peramivir.svg|200x200px]]
| [[File:Laninamivir.svg|200x200px]]
|-
| [[扎那米韦|扎那米韦]]
| [[奥司他韦|奥司他韦]]
| [[帕拉米韦|帕拉米韦]]
| [[拉尼米韦|拉尼米韦]]
|}

==天然产物中的神经氨酸酶抑制剂==
*矢车菊素-3-桑布双糖苷 （从[[西洋接骨木|西洋接骨木]]中提取）<ref>{{ cite journal |vauthors=Swaminathan K, Dyason JC, Maggioni A, von Itzstein M, Downard KM | title = Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry | journal = Anal Bioanal Chem | year = 2013 | volume = 405 | issue = 20 | pages = 6563–72 | doi = 10.1007/s00216-013-7068-x | pmid = 23748498 }}</ref>
*[[黄连碱|黄连碱]]
*[[黄连素|黄连素]]<ref>{{Cite journal|last=Kim|first=Jang Hoon|last2=Ryu|first2=Young Bae|last3=Lee|first3=Woo Song|last4=Kim|first4=Young Ho|date=2014-11-01|title=Neuraminidase inhibitory activities of quaternary isoquinoline alkaloids from Corydalis turtschaninovii rhizome|journal=Bioorganic & Medicinal Chemistry|volume=22|issue=21|pages=6047–6052|doi=10.1016/j.bmc.2014.09.004|issn=1464-3391|pmid=25277281|doi-access=free}}</ref>

== 参考文献 ==
{{Reflist}}

[[Category:糖化学|Category:糖化学]]
[[Category:神经氨酸酶抑制剂|Category:神经氨酸酶抑制剂]]